Literature DB >> 18172611

Brain angiotensin receptors and binding proteins.

Robert C Speth1, Vardan T Karamyan.   

Abstract

This review addresses classical and novel aspects of the brain angiotensin system. The brain contains both the AT1 and AT2 angiotensin II (Ang II) receptor subtypes which are well-characterized guanine nucleotide binding protein (G protein)-coupled receptors (GPCRs). Like other GPCRs, novel signal transduction pathways and protein interactions are being described for Ang II receptors. For brain AT1 receptors, there is a controversy regarding the identity of the active angiotensin peptide in the brain which is addressed in this review. This review also summarizes a recent discovery of a novel, membrane-bound, non-AT1, non-AT2 binding site for angiotensin peptides that appears to be brain-specific. This binding site is unmasked by a limited concentration range of the organometallic sulfhydryl-reactive agent p-chloromercuribenzoic acid (PCMB) suggesting that functional expression of this binding site may depend on the redox state of the milieu of the brain. While this binding site has similarities to a previously described soluble angiotensin-binding protein found in liver that is unmasked by PCMB, it has many different characteristics. The possible functional significance of this novel non-AT1, non-AT2 binding site for angiotensin peptides as a mediator of non-traditional actions of Ang II in the brain, e.g., stimulation of dopamine release from the striatum, as a peptidase, or as a clearance receptor, and the importance of the state of the internal environment of the brain to its function is reviewed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18172611     DOI: 10.1007/s00210-007-0238-7

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  95 in total

Review 1.  Angiotensin III: a central regulator of vasopressin release and blood pressure.

Authors:  A Reaux; M C Fournie-Zaluski; C Llorens-Cortes
Journal:  Trends Endocrinol Metab       Date:  2001 May-Jun       Impact factor: 12.015

2.  Tails of the L-type Ca(2+) channel: to sense oxygen or not.

Authors:  A Yatani; T J Kamp
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

3.  Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16.

Authors:  P Dahms; R Mentlein
Journal:  Eur J Biochem       Date:  1992-08-15

4.  Purification and properties of a soluble angiotensin II-binding protein from rabbit liver.

Authors:  M A Kiron; R L Soffer
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

5.  Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor.

Authors:  L Daviet; J Y Lehtonen; K Tamura; D P Griese; M Horiuchi; V J Dzau
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

Review 6.  Redox control of neural function: background, mechanisms, and significance.

Authors:  Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2006 Nov-Dec       Impact factor: 8.401

7.  Superoxide mediates the actions of angiotensin II in the central nervous system.

Authors:  Matthew C Zimmerman; Eric Lazartigues; Julie A Lang; Puspha Sinnayah; Iman M Ahmad; Douglas R Spitz; Robin L Davisson
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

8.  UDP-galactose 4-epimerase from Kluyveromyces fragilis: reconstitution of holoenzyme structure after dissociation with parachloromercuribenzoate.

Authors:  S Majumdar; H Bhattacharjee; D Bhattacharyya; A Bhaduri
Journal:  Eur J Biochem       Date:  1998-10-15

9.  Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant DEFENSE.

Authors:  Samantha M Beer; Ellen R Taylor; Stephanie E Brown; Christina C Dahm; Nikola J Costa; Michael J Runswick; Michael P Murphy
Journal:  J Biol Chem       Date:  2004-08-30       Impact factor: 5.157

10.  Characterization of a membrane glycoprotein having pharmacological and biochemical properties of an AT2 angiotensin II receptor from human myometrium.

Authors:  D Lazard; P Villageois; M M Briend-Sutren; F Cavaillé; S Bottari; A D Strosberg; C Nahmias
Journal:  Eur J Biochem       Date:  1994-03-15
View more
  5 in total

1.  AT₁ angiotensin II receptor and novel non-AT₁, non-AT₂ angiotensin II/III binding site in brainstem cardiovascular regulatory centers of the spontaneously hypertensive rat.

Authors:  Erick A Bourassa; Xiefan Fang; Xia Li; Alan F Sved; Robert C Speth
Journal:  Brain Res       Date:  2010-08-31       Impact factor: 3.252

Review 2.  Angiotensin and carotid body chemoreception in heart failure.

Authors:  Harold D Schultz
Journal:  Curr Opin Pharmacol       Date:  2011-01-15       Impact factor: 5.547

Review 3.  An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy.

Authors:  Justin L Grobe; Di Xu; Curt D Sigmund
Journal:  Physiology (Bethesda)       Date:  2008-08

4.  Distribution of a novel binding site for angiotensins II and III in mouse tissues.

Authors:  Felicia M Rabey; Vardan T Karamyan; Robert C Speth
Journal:  Regul Pept       Date:  2010-02-19

5.  Renin-Angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension.

Authors:  Kazushi Tsuda
Journal:  Int J Hypertens       Date:  2012-11-21       Impact factor: 2.420

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.